Cardiometabolic disorders and menopausal hormone therapy
The review highlights the role of endo- and exogenous estrogens and androgens in the genesis of cardiometabolic disorders in postmenopausal women and the role of menopausal hormone therapy in their prevention.
Main Authors: | V Ye Balan, L M Ilina, E V Tikhomirova, A V Tsarkova, I N Lazareva, D V Grigorieva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2017-10-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/30008/pdf |
Similar Items
-
Correction of menopausal disorders: new possibilities of menopausal hormone therapy
by: L. Yu. Karakhalis
Published: (2022-04-01) -
New trends in current menopausal hormone therapy
by: Vera E. Balan, et al.
Published: (2021-03-01) -
Management of menopausal women with a history of endometriosis
by: Elena I. Ermakova, et al.
Published: (2020-04-01) -
Evaluating the effectiveness of alternative treatments for menopausal symptoms in postmenopausal women
by: S V Yureneva, et al.
Published: (2017-02-01) -
Individual choice of menopausal hormone therapy
by: T V Ovsyannikova, et al.
Published: (2016-08-01)